Reading view
WaterCopilot: An AI-Driven Virtual Assistant for Water Management
All Required, In Order: Phase-Level Evaluation for AI-Human Dialogue in Healthcare and Beyond
GI-Bench: A Panoramic Benchmark Revealing the Knowledge-Experience Dissociation of Multimodal Large Language Models in Gastrointestinal Endoscopy Against Clinical Standards
Moral Lenses, Political Coordinates: Towards Ideological Positioning of Morally Conditioned LLMs
ISLA: A U-Net for MRI-based acute ischemic stroke lesion segmentation with deep supervision, attention, domain adaptation, and ensemble learning
DeKeyNLU: Enhancing Natural Language to SQL Generation through Task Decomposition and Keyword Extraction
Generative Digital Twins: Vision-Language Simulation Models for Executable Industrial Systems
Explainable Molecular Property Prediction: Aligning Chemical Concepts with Predictions via Language Models
Hallucination, reliability, and the role of generative AI in science
Efficient and Reproducible Biomedical Question Answering using Retrieval Augmented Generation
STAT+: On Day 2 of JPM, Gilead lays outs it next test, a VC looks to raise funds, and one firm has FDA whiplash
This is the online version of The Readout, STATβs flagship biotech newsletter.Β Sign upΒ to get it in your inbox.
Youβre back. Weβre sort of back. Itβs Day 2 of JPM and weβre definitely not exhausted or delirious yet.
This is Elaine Chen, Adam Feuerstein, Matt Herper, and Allison DeAngelis again. Weβve got a lot more news today, so letβs get to it.
The next test for Kite Pharma β and Gilead
Itβs anito-cel, the CAR-T therapy for multiple myeloma that Gilead is developing in partnership with Arcellx. Gilead submitted the therapy to the FDA sometime before the end of December, Cindy Perettie, executive vice president of Kite Pharma, the cell therapy division of Gilead, told STAT at a Gilead media breakfast.
Continue to STAT+ to read the full storyβ¦


Β© Alex Hogan/STAT
Geometric multi-instance learning for weakly supervised gastric cancer segmentation
npj Digital Medicine, Published online: 13 January 2026; doi:10.1038/s41746-025-02287-6
Geometric multi-instance learning for weakly supervised gastric cancer segmentation